Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 44

Results For "March"

913 News Found

GlobalData predicts product cannibalization within electrophysiology ablation space
News | October 12, 2023

GlobalData predicts product cannibalization within electrophysiology ablation space

PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm


Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan
News | October 11, 2023

Astellas, BioLabs and Mitsui Fudosan collaborate to enhance life science ecosystems in Tsukuba and Kashiwa-no-ha, Japan

Astellas stands on the forefront of healthcare change to turn innovative science into value for patients


Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib
Drug Approval | October 09, 2023

Sun Pharma gets USFDA filing acceptance of new drug application for Deuruxolitinib

The NDA filing for deuruxolitinib with the U.S. FDA is based on two pivotal Phase III trials


Dishman Carbogen Amcis updates on inspection by EDQM and AIFA
Drug Approval | September 22, 2023

Dishman Carbogen Amcis updates on inspection by EDQM and AIFA

The company's Bavla site was successfully jointly inspected by the EDQM and Italian Medicines Agency (AIFA)


Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries
News | August 17, 2023

Aurobindo to launch HIV triple combination product for children living with HIV in low and middle-income countries

Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon


Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr
News | August 13, 2023

Aurobindo Pharma reports Q1 FY24 consolidated PAT at Rs. 570.75 Cr

Aurobindo Pharma has reported total income of Rs. 6966.85 crores during the period ended June 30, 2023


Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr
News | August 13, 2023

Krsnaa Diagnostics posts Q1 FY24 consolidated PAT at Rs. 14.64 Cr

Krsnaa Diagnostics has reported total income of Rs. 143.80 crores during the period ended June 30, 2023


Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr
News | August 13, 2023

Panacea Biotec posts Q1 FY24 consolidated PAT at Rs. 10.98 Cr

Panacea Biotec has reported total income of Rs. 135.27 crores during the period ended June 30, 2023


Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr
News | August 12, 2023

Gujarat Themis Biosyn posts Q1 FY24 PAT at Rs. 17.72 Cr

Gujarat Themis Biosyn has reported total income of Rs. 50.66 crores during the period ended June 30, 2023


IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr
News | August 12, 2023

IPCA Laboratories posts Q1 FY24 consolidated PAT at Rs. 162.82 Cr

IPCA Laboratories has reported total income of Rs. 1632.43 crores during the period ended June 30, 2023